146 related articles for article (PubMed ID: 38382469)
1. Opening the K
Gandini MA; Zamponi GW
Cell Rep Med; 2024 Feb; 5(2):101425. PubMed ID: 38382469
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapy improves cellular dysfunction, ataxia, and seizure susceptibility in a model of a progressive myoclonus epilepsy.
Feng H; Clatot J; Kaneko K; Flores-Mendez M; Wengert ER; Koutcher C; Hoddeson E; Lopez E; Lee D; Arias L; Liang Q; Zhang X; Somarowthu A; Covarrubias M; Gunthorpe MJ; Large CH; Akizu N; Goldberg EM
Cell Rep Med; 2024 Feb; 5(2):101389. PubMed ID: 38266642
[TBL] [Abstract][Full Text] [Related]
3. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK) is caused by heterozygous KCNC1 mutations.
Nascimento FA; Andrade DM
Epileptic Disord; 2016 Sep; 18(S2):135-138. PubMed ID: 27629860
[TBL] [Abstract][Full Text] [Related]
4. Myoclonus epilepsy and ataxia due to potassium channel mutation (MEAK): a cause of progressive myoclonic epilepsy.
Mahale RR; Tiwari R; Arunachal G; Padmanabha H; Mailankody P
Acta Neurol Belg; 2022 Jun; 122(3):801-803. PubMed ID: 33725338
[No Abstract] [Full Text] [Related]
5. Pharmacological rescue of mutated K
Munch AS; Saljic A; Boddum K; Grunnet M; Hougaard C; Jespersen T
Eur J Pharmacol; 2018 Aug; 833():255-262. PubMed ID: 29894724
[TBL] [Abstract][Full Text] [Related]
6. A KCNC1-related neurological disorder due to gain of Kv3.1 function.
Clatot J; Ginn N; Costain G; Goldberg EM
Ann Clin Transl Neurol; 2023 Jan; 10(1):111-117. PubMed ID: 36419348
[TBL] [Abstract][Full Text] [Related]
7. Progressive myoclonus epilepsy caused by a gain-of-function KCNA2 mutation.
Canafoglia L; Castellotti B; Ragona F; Freri E; Granata T; Chiapparini L; Gellera C; Scaioli V; Franceschetti S; DiFrancesco JC
Seizure; 2019 Feb; 65():106-108. PubMed ID: 30660924
[No Abstract] [Full Text] [Related]
8. Zonisamide-responsive myoclonus in SEMA6B-associated progressive myoclonic epilepsy.
Herzog R; Hellenbroich Y; Brüggemann N; Lohmann K; Grimmel M; Haack TB; von Spiczak S; Münchau A
Ann Clin Transl Neurol; 2021 Jul; 8(7):1524-1527. PubMed ID: 34092044
[TBL] [Abstract][Full Text] [Related]
9. A novel variant of dehydrodolichol diphosphate synthase (DHDDS) mutation with adult-onset progressive myoclonus ataxia.
Kim J; Kim I; Koh SB
Parkinsonism Relat Disord; 2021 Jun; 87():135-136. PubMed ID: 34034154
[TBL] [Abstract][Full Text] [Related]
10. Transcranial magnetic stimulation in progressive myoclonus epilepsy: A promising tool for "deep phenotyping" in genetic epilepsies.
Rubboli G; Valzania F
Epilepsia; 2023 Sep; 64(9):2534-2535. PubMed ID: 37453054
[No Abstract] [Full Text] [Related]
11. Progressive myoclonic epilepsy: myoclonic epilepsy and ataxia due to KCNC1 mutation (MEAK): a case report and review of the literature.
Barot N; Margiotta M; Nei M; Skidmore C
Epileptic Disord; 2020 Oct; 22(5):654-658. PubMed ID: 32972906
[TBL] [Abstract][Full Text] [Related]
12. Novel mutation in potassium channel related gene KCTD7 and progressive myoclonic epilepsy.
Krabichler B; Rostasy K; Baumann M; Karall D; Scholl-Bürgi S; Schwarzer C; Gautsch K; Spreiz A; Kotzot D; Zschocke J; Fauth C; Haberlandt E
Ann Hum Genet; 2012 Jul; 76(4):326-31. PubMed ID: 22606975
[TBL] [Abstract][Full Text] [Related]
13. Neuroinflammation and progressive myoclonus epilepsies: from basic science to therapeutic opportunities.
Sanz P; Serratosa JM
Expert Rev Mol Med; 2020 Sep; 22():e4. PubMed ID: 32938505
[TBL] [Abstract][Full Text] [Related]
14. A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
Muona M; Berkovic SF; Dibbens LM; Oliver KL; Maljevic S; Bayly MA; Joensuu T; Canafoglia L; Franceschetti S; Michelucci R; Markkinen S; Heron SE; Hildebrand MS; Andermann E; Andermann F; Gambardella A; Tinuper P; Licchetta L; Scheffer IE; Criscuolo C; Filla A; Ferlazzo E; Ahmad J; Ahmad A; Baykan B; Said E; Topcu M; Riguzzi P; King MD; Ozkara C; Andrade DM; Engelsen BA; Crespel A; Lindenau M; Lohmann E; Saletti V; Massano J; Privitera M; Espay AJ; Kauffmann B; Duchowny M; Møller RS; Straussberg R; Afawi Z; Ben-Zeev B; Samocha KE; Daly MJ; Petrou S; Lerche H; Palotie A; Lehesjoki AE
Nat Genet; 2015 Jan; 47(1):39-46. PubMed ID: 25401298
[TBL] [Abstract][Full Text] [Related]
15. Differential diagnosis of familial adult myoclonic epilepsy.
Baykan B; Franceschetti S; Canafoglia L; Cavalleri GL; Michelucci R; Scheffer IE
Epilepsia; 2023 Jun; 64 Suppl 1():S52-S57. PubMed ID: 36751956
[TBL] [Abstract][Full Text] [Related]
16. A novel SCARB2 mutation causing late-onset progressive myoclonus epilepsy.
Higashiyama Y; Doi H; Wakabayashi M; Tsurusaki Y; Miyake N; Saitsu H; Ohba C; Fukai R; Miyatake S; Joki H; Koyano S; Suzuki Y; Tanaka F; Kuroiwa Y; Matsumoto N
Mov Disord; 2013 Apr; 28(4):552-3. PubMed ID: 23325613
[No Abstract] [Full Text] [Related]
17. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
de Haan GJ; Halley DJ; Deelen WH; Lindhout D
Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
[TBL] [Abstract][Full Text] [Related]
18. Progressive myoclonus epilepsies due to SEMA6B mutations. New variants and appraisal of published phenotypes.
Castellotti B; Canafoglia L; Freri E; Tappatà M; Messina G; Magri S; DiFrancesco JC; Fanella M; Di Bonaventura C; Morano A; Granata T; Gellera C; Franceschetti S; Michelucci R
Epilepsia Open; 2023 Jun; 8(2):645-650. PubMed ID: 36719163
[TBL] [Abstract][Full Text] [Related]
19. KCTD7-related progressive myoclonus epilepsy.
Van Bogaert P
Epileptic Disord; 2016 Sep; 18(S2):115-119. PubMed ID: 27629772
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations consolidate KCTD7 as a progressive myoclonus epilepsy gene.
Kousi M; Anttila V; Schulz A; Calafato S; Jakkula E; Riesch E; Myllykangas L; Kalimo H; Topçu M; Gökben S; Alehan F; Lemke JR; Alber M; Palotie A; Kopra O; Lehesjoki AE
J Med Genet; 2012 Jun; 49(6):391-9. PubMed ID: 22693283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
